| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Changes in outcome of patients with advanced non-clear cell renal cell carcinoma from the tyrosine kinase inhibitor era to the immuno-oncology era
|
Ishihara, Hiroki
|
|
|
29 |
11 |
p. 1730-1739
|
artikel
|
| 2 |
Comparison of olanzapine 2.5 mg and 5 mg in the prevention of chemotherapy-induced nausea and vomiting: a Japanese nationwide database study
|
Suzuki-Chiba, Hiroe
|
|
|
29 |
11 |
p. 1762-1773
|
artikel
|
| 3 |
Current status and prospects of artificial intelligence in breast cancer pathology: convolutional neural networks to prospective Vision Transformers
|
Katayama, Ayaka
|
|
|
29 |
11 |
p. 1648-1668
|
artikel
|
| 4 |
Current status and prospects of breast cancer imaging-based diagnosis using artificial intelligence
|
Sekine, Chikako
|
|
|
29 |
11 |
p. 1641-1647
|
artikel
|
| 5 |
Current status of BAFF targeting immunotherapy in B-cell neoplasm
|
Tagami, Nami
|
|
|
29 |
11 |
p. 1676-1683
|
artikel
|
| 6 |
Defining the clinical benefits of adding a neurokinin-1 receptor antagonist to control chemotherapy-induced nausea and vomiting in moderately emetogenic chemotherapy: a systematic review and meta-analysis of the clinical practice guidelines for antiemesis 2023 from the Japan society of clinical oncology
|
Hayashi, Toshinobu
|
|
|
29 |
11 |
p. 1616-1631
|
artikel
|
| 7 |
Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with highly emetogenic risk antineoplastic agents: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology
|
Yokomizo, Ayako
|
|
|
29 |
11 |
p. 1632-1640
|
artikel
|
| 8 |
Identification of clinical prognosis features and significant DNA methylation regulation in pineoblastoma
|
Shao, Kongfeng
|
|
|
29 |
11 |
p. 1704-1714
|
artikel
|
| 9 |
Long-term outcomes of sentinel lymph node navigation surgery for early-stage cervical cancer
|
Togami, Shinichi
|
|
|
29 |
11 |
p. 1740-1745
|
artikel
|
| 10 |
Lynch syndrome screening in patients with young-onset extra-colorectal Lynch syndrome-associated cancers
|
Yamada, Atsushi
|
|
|
29 |
11 |
p. 1696-1703
|
artikel
|
| 11 |
Maediastinal germ cell tumors: analysis using hospital-based cancer registry data in Japan
|
Takahashi, Reo
|
|
|
29 |
11 |
p. 1756-1761
|
artikel
|
| 12 |
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of alectinib and pembrolizumab for the adjuvant treatment of non-small cell lung cancer in Japan
|
Matsumura, Noriomi
|
|
|
29 |
11 |
p. 1615
|
artikel
|
| 13 |
Predicting invasive disease-free survival in ER-positive, HER2-negative early breast cancer using the PAM50 risk-of-recurrence score: a retrospective analysis using single-center long-term follow-up data of postmenopausal Japanese patients
|
Higami, Akane
|
|
|
29 |
11 |
p. 1715-1720
|
artikel
|
| 14 |
Preliminary results from ASCENT-J02: a phase 1/2 study of sacituzumab govitecan in Japanese patients with advanced solid tumors
|
Naito, Yoichi
|
|
|
29 |
11 |
p. 1684-1695
|
artikel
|
| 15 |
Prognosis of early-onset vs. late-onset stage II/III colorectal cancer patients with adjuvant chemotherapy: a multicenter propensity score matched study
|
Okamoto, Kazuaki
|
|
|
29 |
11 |
p. 1721-1729
|
artikel
|
| 16 |
Research on biomarkers using innovative artificial intelligence systems in breast cancer
|
Kurozumi, Sasagu
|
|
|
29 |
11 |
p. 1669-1675
|
artikel
|
| 17 |
Results of the JRS-I LRA0401 and LRB0402 Japan Rhabdomyosarcoma Study Group trials for low-risk embryonal rhabdomyosarcoma
|
Hosoi, Hajime
|
|
|
29 |
11 |
p. 1746-1755
|
artikel
|
Tijdschrift beschrijving